Idiopathic Pulmonary Fibrosis: Best Practice in Monitoring and Managing a Relentless Fibrotic Disease
Wim Wuyts(Universitair Ziekenhuis Leuven), Elisabeth Bendstrup(Aarhus University Hospital), Demosthenes Bouros(Democritus University of Thrace), Paul Bresser(OLVG), Benjamin Bondue(Université Libre de Bruxelles), Marlies Wijsenbeek(Erasmus University Rotterdam), Ole Hilberg(Lillebaelt Hospital), Spyridon Papiris(National and Kapodistrian University of Athens), António Morais(Instituto Português de Oncologia Francisco Gentil), Effrosyni D. Manali(National and Kapodistrian University of Athens), Jesper Magnusson(University of Gothenburg), Carlos Robalo Cordeiro(Imperial College London), Saher Burhan Shaker(Gentofte Hospital), Marcel Veltkamp(University Medical Center Utrecht)
Cited by 93
Related Papers
An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias
|American Journal of Respiratory and Critical Care Medicine|2013|4.3k
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
|American Journal of Respiratory and Critical Care Medicine|2018|4.1k
Diagnosis of Hypersensitivity Pneumonitis in Adults: An Official ATS/JRS/ALAT Clinical Practice Guideline
|American Journal of Respiratory and Critical Care Medicine|2020|1k
Antifungal lactic acid bacteria as biopreservatives
|Trends in Food Science & Technology|2005|685
ERS clinical practice guidelines on treatment of sarcoidosis
|European Respiratory Journal|2021|579